Get the Stockscreener App
79.83
2.60%
-2.13
After Hours:
80.49
0.66
+0.83%
Sol Gel Technologies Ltd stock is traded at $79.83, with a volume of 47,206.
It is down -2.60% in the last 24 hours and up +8.61% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
See More
Previous Close:
$81.96
Open:
$82.36
24h Volume:
47,206
Relative Volume:
1.40
Market Cap:
$260.96M
Revenue:
$18.47M
Net Income/Loss:
$-1.05M
P/E Ratio:
-227.24
EPS:
-0.3513
Net Cash Flow:
$-33.87M
1W Performance:
-0.34%
1M Performance:
+8.61%
6M Performance:
+35.31%
1Y Performance:
+625.73%
1-Day Range:
$79.77
$85.98
1-Week Range:
$77.10
$93.74
52-Week Range:
$10.77
$97.97
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
79.83 | 267.93M | 18.47M | -1.05M | -33.87M | -0.3513 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SLGL|Sol Gel Technologies Ltd|Price:81.960|Chg%:+1.410 - TradingKey
Sol Gel Technologies Ltd (SLGL) Cash Flow - TradingKey
Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sol Gel Technologies Ltd (SLGL) Institutional Confidence - TradingKey
TradingKey - TradingKey
Sol-Gel Technologies Ltd. Revenue Breakdown – FWB:4SG - TradingView
Sol Gel Technologies Ltd (SLGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunit - Benzinga
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
SLGL Reiterated by HC Wainwright & Co. -- Rating Remains Buy - GuruFocus
H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target - Investing.com
Opaleye Management Inc. Acquires Additional Shares in Sol-Gel Technologies Ltd - GuruFocus
Sol-Gel Technologies (NASDAQ: SLGL) holder adds 1,695 shares - Stock Titan
Opaleye Management (SLGL) adds Sol-Gel stake with open-market share purchases - Stock Titan
SLGL Q1 2026 Earnings: Narrower Net Loss Beats Street Estimates Despite No RevenueDiluted EPS Report - dars.gov.et
SLGL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock MovementGuidance Upgrade Report - dars.gov.et
SLGL Technical Analysis & Stock Price Forecast - Intellectia AI
Opaleye boosts Sol-Gel (SLGL) stake with 1,712-share open-market buy - Stock Titan
TKNO Stock Price and Chart — NASDAQ:TKNO - TradingView
Sol-Gel Technologies Ltd. Actuals & Estimates (NASDAQ:SLGL) - TradingView
SLGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Price to sales forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Enterprise value to revenue forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Sahm
SLGL Initiates Coverage On Mizuho -- Rating Set to Outperform - GuruFocus
Mizuho Securities Initiates Coverage on Sol-Gel With Outperform Rating, $285 Price Target - Moomoo
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Mizuho initiates Sol Gel stock with Outperform on BCC therapy potential - Investing.com South Africa
Sol-Gel Technologies Initiated at Outperform by Mizuho - Moomoo
ETFs Investing in Sol-Gel Technologies Ltd. Stocks - TradingView
Certain Ordinary Shares of Sol-Gel Technologies Ltd. are subject to a Lock-Up Agreement Ending on 22-JUN-2026. - marketscreener.com
Sol-Gel Technologies (SLGL) Surges 3.4% as Shares Test Key Resistance ZoneHigh Conviction Picks - DonanımHaber
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sol Gel Technologies Ltd (SLGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SLGL Q1 2026 Earnings: EPS Surprises to the Upside as Cost Discipline Takes HoldDownward Estimate Revision - newsline.com
Sol-Gel Technologies (SLGL) Faces Slight Pullback Near ResistanceAdvance Decline Volume - dars.gov.et
Phoenix Financial Ltd. (SLGL) reports 4.99% ownership of Sol‑Gel shares - Stock Titan
Sol-Gel Technologies Ltd. Q1 2026 Earnings: EPS Beat Drives Modest Stock Uptick Despite Continued Pre-Revenue StatusGuidance Update - newsline.com
SLGL Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Stock HigherNext Quarter Guidance - newsline.com
SLGLSol-Gel Technologies Ltd Stock Price and Quote - Finviz
TD Cowen initiates Sol Gel stock with buy on dermatology drug - Investing.com Nigeria
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184 - Moomoo
TD Cowen Initiates Sol-Gel Technologies at Buy - Moomoo
Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative - simplywall.st
Sol-Gel Technologies (SLGL) Reports First Quarter Revenue Decline - GuruFocus
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):